Wenbin Rui
Overview
Explore the profile of Wenbin Rui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Yang X, Yang X, Xie X, Rui W, He H
Technol Cancer Res Treat
. 2024 Dec;
23:15330338241307686.
PMID: 39703069
Clear cell renal cell carcinoma (ccRCC) is a highly lethal urinary malignancy with poor overall survival (OS) rates. Integrating computer vision and machine learning in pathomics analysis offers potential for...
2.
Xie X, Huang F, Yao J, Teng S, Gao Y, Chen L, et al.
Expert Rev Med Devices
. 2024 Dec;
21(12):1211-1217.
PMID: 39659170
Background: The advent of ultrasonic scalpels has remarkably advanced minimally invasive surgery; however, the Chinese market's reliance on imports highlights the urgent need for a cost-effective, efficient, and domestically produced...
3.
Hao Y, He W, Wang H, Rui W, Sun F, Zhu Y, et al.
Oncol Rep
. 2023 Aug;
50(3).
PMID: 37539708
The downregulated expression of forkhead box F1 (FOXF1) has been found in many malignant tumors but no research was done in bladder cancer (BC). The present study aimed to investigate...
4.
Wang X, He H, Rui W, Zhang N, Zhu Y, Xie X
J Transl Med
. 2021 Dec;
19(1):508.
PMID: 34906161
Background: Loss-of-function mutations or abnormal expressions of E ubiquitin ligases contributes to tumorigenesis. TRIM38 was reported to regulate immunity, inflammatory responses or apoptosis, but its roles in tumor progression remain...
5.
Xie X, He H, Zhang N, Wang X, Rui W, Xu D, et al.
Technol Cancer Res Treat
. 2020 Nov;
19:1533033820973277.
PMID: 33234027
Purpose: Discoidin domain receptor 1 (DDR1) belongs to a novel class of receptor tyrosine kinases. Previous evidence indicates that DDR1 overexpression promotes the aggressive growth of bladder cancer (BC) cells....
6.
He W, He H, Zhang N, Rui W, Wang X, Zhu Y, et al.
J BUON
. 2020 Aug;
25(3):1619-1624.
PMID: 32862613
Purpose: To explore the associations between the expressions of micro ribonucleic acid (miR)-135 and miR-92a and the pathogenesis of prostate cancer, as well as their clinical significance. Methods: A total...
7.
Wang X, He H, Rui W, Xie X, Wang D, Zhu Y
Onco Targets Ther
. 2020 Apr;
13:2483-2490.
PMID: 32273720
Background: Bladder cancer is a serious threat to human health. It is meaningful to study the pathogenesis of bladder cancer. Long non-coding RNAs (lncRNAs) are reported to promote or inhibit...
8.
Zhao J, Dai J, Zhou W, Wang H, Rui W, He W, et al.
Oncotarget
. 2017 Dec;
8(54):93251-93257.
PMID: 29190995
Study about blood pressure variation in the first 24 hours post-operation is limited in patients with adrenal aldosterone-producing adenoma. We aim to evaluate the potential predictors for postoperative hypertension urgency...
9.
Xie X, Rui W, He W, Shao Y, Sun F, Zhou W, et al.
Am J Transl Res
. 2017 Jun;
9(5):2500-2507.
PMID: 28560000
Discoidin domain receptor 1 (DDR1) is a receptor tyrosine kinase which utilizes collagen as a ligand to regulate the interaction between cancer cells and tumor stroma. However, the clinical relevance...
10.
Fang H, Xiao M, Rui W, Du J, Tao Z
Sci Rep
. 2016 Apr;
6:24300.
PMID: 27063998
A new spintronic theory has been developed for the magnetic tunnel junction (MTJ) with single-crystal barrier. The barrier will be treated as a diffraction grating with intralayer periodicity, the diffracted...